Autosomal Recessive Spastic Ataxia Of Charlevoix-saguenay

Table of contents:

Description
Related genes
Clinical Features
Incidence and onset information
Alternative Names
Researches and researchers
Gene Panels
Sources and references

Description

Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a neurodegenerative disorder characterised by early-onset cerebellar ataxia with spasticity, a pyramidal syndrome and peripheral neuropathy.

Genes related to Autosomal Recessive Spastic Ataxia Of Charlevoix-saguenay

SACS

View recommended genes panels

Clinical Features

Top most frequent phenotypes and symptoms related to Autosomal Recessive Spastic Ataxia Of Charlevoix-saguenay

Intellectual disability
Seizures
Hearing impairment
Scoliosis
Ataxia
Nystagmus
Muscle weakness
Spasticity
Motor delay
Peripheral neuropathy

And another 68 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.

Alternative names

Autosomal Recessive Spastic Ataxia Of Charlevoix-saguenay Is also known as autosomal recessive spastic ataxia type 6, charlevoix-saguenay spastic ataxia, autosomal recessive spastic ataxia of charlevoix-saguenay, spax6, spastic ataxia 6, autosomal recessive, arsacs.

Researches and researchers

Doctors, researchs, and experts related to Autosomal Recessive Spastic Ataxia Of Charlevoix-saguenay extracted from public data.

Autosomal Recessive Spastic Ataxia Of Charlevoix-saguenay Experts map

Current Researchs and researchers

JONQUIÈRE — Dr Cynthia GAGNON
Investigator of research project
- Institution/s:
  — École de réadaptation (site Saguenay), FMSS, Université de Sherbrooke, CSSS - Centre de santé et de services sociaux de Jonquière
- Research area/topic::
  New Emerging Team on Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): from models to treatment strategies

JONQUIÈRE — Dr Jean MATHIEU
Clinical expert - Investigator of research project
- Institution/s:
  — École de réadaptation (site Saguenay), FMSS, Université de Sherbrooke, CSSS - Centre de santé et de services sociaux de Jonquière
- Research area/topic::
  New Emerging Team on Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): from models to treatment strategies

MONTRÉAL — Dr Bernard BRAIS
Investigator of research project
- Institution/s:
  — Centre Hospitalier de l'Université de Montréal
- Research area/topic::
  New Emerging Team on Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): from models to treatment strategies

MONTRÉAL — Pr Heidi MCBRIDE
Investigator of research project
- Institution/s:
  — Neuromuscular Research Group, Montreal Neurological Institute and Hospital
- Research area/topic::
  New Emerging Team on Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): from models to treatment strategies

MONTRÉAL — Pr Rebecca MCKINNEY
Investigator of research project
- Institution/s:
  — McGill University - McIntyre Medical Sciences Building
- Research area/topic::
  New Emerging Team on Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): from models to treatment strategies

MONTRÉAL — Pr Peter MCPHERSON
Investigator of research project
- Institution/s:
  — Montreal Neurological Institute and Hospital
- Research area/topic::
  New Emerging Team on Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): from models to treatment strategies

MONTRÉAL — Pr Eric SHOUBRIDGE
Investigator of research project
- Institution/s:
  — Department of Molecular Neurogenetics, Montreal Neurological Institute and Hospital
- Research area/topic::
  New Emerging Team on Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): from models to treatment strategies

MONTRÉAL — Pr Jason C YOUNG
Investigator of research project
- Institution/s:
  — Department of Biochemistry
- Research area/topic::
  New Emerging Team on Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS): from models to treatment strategies

Autosomal Recessive Spastic Ataxia Of Charlevoix-saguenay Recommended genes panels

Panel Name, Specifity and genes Tested/covered
GeneAware Complete Panel Version 2 (Female). By Baylor Miraca Genetics Laboratories (United States). RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, BTK , (...) View the complete list with 139 more genes Panel complete gene list RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, BTK, TGM1, TH, TTPA, UBE3A, UGT1A1, USH1C, USH2A, CLRN1, WAS, MCOLN1, NPHS2, CDH23, PCDH15, CAPN3, CBS, HPS3, LRPPRC, RTEL1, MLC1, DCLRE1C, ADA, CFTR, CHAT, POMGNT1, CHRNE, SUMF1, DHDDS, TPP1, CLN3, CLN5, CLN6, CLN8, ADAMTS2, COL4A3, CPT1A, ETHE1, CPT2, GNE, MMACHC, TMEM216, CTNS, CTSK, CYBB, CYP1B1, CYP27A1, BBS10, DOK7, DBT, DHCR7, DLD, DMD, GNPTAB, DPYD, AGA, AGL, EIF2B5, AGXT, FAH, FANCC, FKTN, FH, FMR1, ALDH3A2, G6PC, G6PD, SLC37A4, GAA, GALC, GALT, ALDOB, GBA, GCDH, GJB2, GJB6, GLB1, GLDC, ALPL, GRHPR, AMT, HADHA, HBA1, HBA2, HBB, HEXA, HEXB, HMGCL, HSD17B4, IDUA, ABCC8, ELP1, IL2RG, ABCD1, IVD, LAMA3, LAMB3, LAMC2, MAN2B1, MECP2, ARSA, MPI, MPL, ASL, MTTP, ASPA, ASS1, MYO7A, NBN, NEB, NPC1, NPHP1, NPHS1, ATM, OCRL, OTC, PAH, PC, PCCA, PCCB, ATP7B, SLC26A4, PEX1, PEX7, ACADM, PHGDH, SERPINA1, PKHD1, PLA2G6, PMM2, POLG, ACADVL, PPT1, PROP1, BBS1, BBS2, PTS, PEX2, BCKDHA, RAPSN, BCKDHB Specificity 1 % Genes 100 %
GeneAware Complete Panel Version 2 (Male). By Baylor Miraca Genetics Laboratories (United States). RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, TGM1 , (...) View the complete list with 129 more genes Panel complete gene list RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, TGM1, TH, TTPA, UBE3A, UGT1A1, USH1C, USH2A, CLRN1, WAS, MCOLN1, NPHS2, CDH23, PCDH15, CAPN3, CBS, HPS3, LRPPRC, RTEL1, MLC1, DCLRE1C, ADA, CFTR, CHAT, POMGNT1, CHRNE, SUMF1, DHDDS, TPP1, CLN3, CLN5, CLN6, CLN8, ADAMTS2, COL4A3, CPT1A, ETHE1, CPT2, GNE, MMACHC, TMEM216, CTNS, CTSK, CYP1B1, CYP27A1, BBS10, DOK7, DBT, DHCR7, DLD, GNPTAB, DPYD, AGA, AGL, EIF2B5, AGXT, FAH, FANCC, FKTN, FH, ALDH3A2, G6PC, SLC37A4, GAA, GALC, GALT, ALDOB, GBA, GCDH, GJB2, GJB6, GLB1, GLDC, ALPL, GRHPR, AMT, HADHA, HBA1, HBA2, HBB, HEXA, HEXB, HMGCL, HSD17B4, IDUA, ABCC8, ELP1, IVD, LAMA3, LAMB3, LAMC2, MAN2B1, ARSA, MPI, MPL, ASL, MTTP, ASPA, ASS1, MYO7A, NBN, NEB, NPC1, NPHP1, NPHS1, ATM, PAH, PC, PCCA, PCCB, ATP7B, SLC26A4, PEX1, PEX7, ACADM, PHGDH, SERPINA1, PKHD1, PLA2G6, PMM2, POLG, ACADVL, PPT1, PROP1, BBS1, BBS2, PTS, PEX2, BCKDHA, RAPSN, BCKDHB Specificity 1 % Genes 100 %
HSP, Comprehensive Evaluation. By Athena Diagnostics Inc (United States). RTN2, SACS, SPG11, ATL1, SPAST, SPG7, BSCL2, PNPLA6, NIPA1, SPART, SPG21, ZFYVE26, FA2H, AP5Z1, REEP1, CYP7B1, WASHC5, ALS2, HSPD1, KIF5A , (...) View the complete list with 4 more genes Panel complete gene list RTN2, SACS, SPG11, ATL1, SPAST, SPG7, BSCL2, PNPLA6, NIPA1, SPART, SPG21, ZFYVE26, FA2H, AP5Z1, REEP1, CYP7B1, WASHC5, ALS2, HSPD1, KIF5A, L1CAM, KIF1A, PLP1, SLC33A1 Specificity 5 % Genes 100 %
HSP, Supplemental Sporadic Evaluation. By Athena Diagnostics Inc (United States). RTN2, SACS, SPG11, ATL1, BSCL2, PNPLA6, NIPA1, SPART, SPG21, ZFYVE26, FA2H, AP5Z1, REEP1, CYP7B1, WASHC5, ALS2, HSPD1, KIF5A, L1CAM, KIF1A , (...) View the complete list with 2 more genes Panel complete gene list RTN2, SACS, SPG11, ATL1, BSCL2, PNPLA6, NIPA1, SPART, SPG21, ZFYVE26, FA2H, AP5Z1, REEP1, CYP7B1, WASHC5, ALS2, HSPD1, KIF5A, L1CAM, KIF1A, PLP1, SLC33A1 Specificity 5 % Genes 100 %
HSP, Supplemental Recessive Evaluation. By Athena Diagnostics Inc (United States). SACS, PNPLA6, SPART, SPG21, FA2H, AP5Z1, CYP7B1, ALS2, KIF1A Specificity 12 % Genes 100 %
HSP, Complete Recessive Evaluation. By Athena Diagnostics Inc (United States). SACS, SPG11, SPG7, PNPLA6, SPART, SPG21, ZFYVE26, FA2H, AP5Z1, CYP7B1, ALS2, KIF1A Specificity 9 % Genes 100 %
Ataxia, Supplemental Recessive Evaluation. By Athena Diagnostics Inc (United States). SACS, TTPA, APTX, COQ8A, SYNE1, TDP1, SYT14, SIL1, FLVCR1, ANO10, MTPAP, AFG3L2, SETX, GRM1, MRE11, ATM, POLG Specificity 6 % Genes 100 %
Ataxia, Complete Recessive Evaluation. By Athena Diagnostics Inc (United States). SACS, TTPA, APTX, COQ8A, SYNE1, TDP1, SYT14, SIL1, FLVCR1, ANO10, MTPAP, AFG3L2, FXN, SETX, GRM1, MRE11, ATM, POLG Specificity 6 % Genes 100 %

You can get up to 52 more panels with our dedicated tool

Sources and references

You can check the following sources for additional information.

MESH ORPHANET OMIM Rare Disease Symptoms Checker

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 3; DSMA3 MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1 LIPOID CONGENITAL ADRENAL HYPERPLASIA; LCAH GABRIELE-DE VRIES SYNDROME; GADEVS LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY